A worldwide network of aid organizations has spoken out against an award from Mainz corona vaccine developer Biontech with the Nobel Prize in Medicine.
The signatories of a letter to the Nobel Prize Committee released Friday recognize Biontech’s scientific achievement as: „out of the ordinary“ An.
However, they criticize the company’s refusal to „share the successful vaccine recipe with manufacturers in developing countries“.
The Nobel Prize Committee will announce the winners of this year’s Nobel Prizes next week, the Nobel Prize in Medicine on Monday.
Biontech bosses Ugur Sahin and Özlem Türeci have recently been repeatedly mentioned as possible award winners. In September, they already received the most prestigious German medical award from the Paul Ehrlich Foundation.
Accusation of abuse of monopoly
The Nobel Prize is for those who: „have brought mankind the greatest benefit“says the letter from the activists. „Instead, Biontech uses its monopoly to charge very high prices and sell only more than 90 percent of its vaccines to rich countries.“
The founders of Biontech Sahin and Türeci „under the current circumstances“ would receive the Nobel Prize in Medicine „irresponsible“.
[Wenn Sie alle aktuellen Entwicklungen zur Coronavirus-Pandemie live auf Ihr Handy haben wollen, empfehlen wir Ihnen unsere App, die Sie hier für Apple- und Android-Geräte herunterladen können.]
The letter goes back to The People’s Vaccine network, which is responsible for repealing intellectual property regulations COVID-19Vaccines. NGOs such as Oxfam and Avaaz and the UN organization Unaids are involved.
According to the network, corona survivors, relatives of the deceased and medical personnel from developing countries signed the letter.
More than six billion corona vaccine doses have now been administered worldwide. At the Vaccination campaign progress however, there are huge differences.
While in Western Europe If, on average, more than 60 percent of the population is vaccinated, vaccination rates in many African countries are still in the single-digit range. Some countries do not yet vaccinate against the coronavirus.
Non-governmental organizations and developers have therefore been calling for the lifting of patent protection for corona vaccines for months. The pharmaceutical companies strongly reject this. The federal government has not yet supported this move either. (AFP)